Biotech, healthcare and health-tech startups, from drug discovery to care delivery. In the last 12 months Value Add VC tracked 76 venture rounds in Health & Biotech totaling $7.5B across 71 companies, with a median round of $60M. The last three months saw 49 rounds and $5.9B, ahead of the 12-month pace.
| Rounds tracked | Last 3 months | Last 6 months | Last 12 months |
|---|---|---|---|
| Rounds | 49 | 71 | 76 |
| Dollars | $5.9B | $6.9B | $7.5B |
| Companies | 48 | 68 | 71 |
| Median round | $70M | $60M | $60M |
Rounds tracked by Value Add VC from filings, wire releases and news outlets, not a total for the whole market. Private companies only.
| Date | Company | Stage | Amount | Led by |
|---|---|---|---|---|
| Jul 15, 2026 | Neko Health | Series C | $700M | Lightspeed Venture Partners, OG Venture Partners |
| Aug 18, 2026 | Neko Health | Series C | $700M | — |
| Jul 31, 2026 | Function Health | Series B | $450M | — |
| Jul 17, 2026 | Chai Discovery | Series C | $400M | Index Ventures, Sequoia Capital, Dimension |
| Jun 25, 2026 | Ollin Biosciences | Series B | $330M | TCG Crossover |
| Nov 19, 2025 | Function Health | Series B | $298M | Redpoint Ventures |
| Sep 5, 2026 | Scan.com | Series C | $220M | — |
| Mar 26, 2026 | eMed | Series A | $200M | — |
| Oct 20, 2025 | OpenEvidence | Series C | $200M | Google Ventures (GV) |
| Jun 26, 2026 | Osanni Bio | Series B | $190M | — |
| Date | Company | Stage | Amount | Led by |
|---|---|---|---|---|
| Sep 16, 2026 | Fortell | — | $163M | — |
| Sep 16, 2026 | Sling Therapeutics | Series C | $123M | — |
| Sep 15, 2026 | Inspiren | Series C | $70M | — |
| Sep 14, 2026 | Tandem Health | Series B | $100M | — |
| Sep 9, 2026 | DermaSensor | Growth | $5M | — |
| Sep 9, 2026 | MapLight Therapeutics | Follow-on offering | $150M | — |
| Sep 9, 2026 | Rightway Healthcare | — | $155M | — |
| Sep 8, 2026 | Moonwalk Biosciences | Series B | $70M | Alpha Wave Global |
| Sep 5, 2026 | Scan.com | Series C | $220M | — |
| Sep 4, 2026 | Elucid | Series D | $55M | — |
| Sep 4, 2026 | Thyme Care | Series E | $125M | — |
| Sep 3, 2026 | Superluminal | Series B | $60M | — |